Transtubal spread of serous adenocarcinoma of the endometrium: An underrecognized mechanism of metastasis

International Journal of Gynecological Pathology

Volumn 25, Issue 2, 2006, Pages 155-160

  Snyder, Matthew J ^a   Bentley, Rex ^a   Robboy, Stanley J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Metastasis; Transtubal spread; Uterine serous carcinoma

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE METASTASIS; METASTASIS; MYOMETRIUM; PERITONEUM METASTASIS; PRIORITY JOURNAL; UTERINE TUBE TUMOR; UTERUS CANCER; ADENOCARCINOMA; CANCER INVASION; ENDOMETRIUM TUMOR; PATHOLOGY; PERITONEUM; PERITONEUM TUMOR; UTERINE TUBE;

ADENOCARCINOMA, SCIRRHOUS; ENDOMETRIAL NEOPLASMS; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; PERITONEUM;

EID: 33747166780     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000179614.47838.82     Document Type: Article

References (20)

1. Hendrickson M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;6:93-108.
2. Gallion HH, Van Nagell JR, Powell DF, et al. Stage I serous papillary carcinoma of the endometrium. Cancer 1989;63:2224-8.
3. Abeler VM, Kjorstad KE. Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases. Gynecol Oncol 1990;39:266-71.
4. Cirisano FD, Robboy SJ, Dodge RK, et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol 1999;74:385-94.
5. Sherman ME, Bitterman P, Rosenshein NB, et al. Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992;16:600-10.
6. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 1992;47:298-305.
7. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987;60:2035-41.
8. Chuang L, Burke TW, Tornos C, et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 1995;58:189-93.
9. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992;69:1424-31.
10. Goff BA, Kato D, Schmidt RA, et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994;54:264-8.
11. Gehrig PA, Groben PA, Fowler WC, et al. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol 2001;97:153-7.
12. Carcangiu ML, Tan LK, Chambers JT. Stage IA uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol 1997;21:1507-14.
13. Lauchlan SC. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med 1981;105:615-8.
14. Lee KR, Belinson JL. Recurrence in noninvasive endometrial carcinoma: relationship to uterine papillary serous carcinoma. Am J Surg Pathol 1991;15:965-73.
15. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 1990;3:120-8.
16. Sampson JA. Carcinoma of the tubes and ovaries secondary to carcinoma of the body of the uterus. Am J Pathol 1934;10:1-27.
17. Holcomb K, Delatorre R, Pedemonte B, et al. E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium. Obstet Gynecol 2002;100:1290-5.
18. Schosshauer PW, Hedrick Ellenson L, Soslow RA. A-Catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Mod Pathol 2002;15:1032-7.
19. Kallakury BV, Ambros RA, Hayner-Buchan AM, et al. Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes. Int J Gynecol Pathol 1998;17:320-6.
20. Hosford S, Elliott J, Ma ZW, et al. CD44 expression in papillary serous endometrial carcinoma. Int J Gynecol Cancer 2003;13:480-4.